Literature DB >> 32946850

Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features.

Ehab Billatos1, Samuel Y Ash2, Fenghai Duan3, Ke Xu4, Justin Romanoff3, Helga Marques3, Elizabeth Moses5, MeiLan K Han6, Elizabeth A Regan7, Russell P Bowler8, Stefanie E Mason2, Tracy J Doyle9, Rubén San José Estépar10, Ivan O Rosas9, James C Ross11, Xiaohui Xiao5, Hanqiao Liu5, Gang Liu5, Gauthaman Sukumar12, Matthew Wilkerson12, Clifton Dalgard13, Christopher Stevenson14, Duncan Whitney14, Denise Aberle15, Avrum Spira16, Raúl San José Estépar10, Marc E Lenburg4, George R Washko2.   

Abstract

BACKGROUND: Chronic tobacco smoke exposure results in a broad range of lung pathologies including emphysema, airway disease and parenchymal fibrosis as well as a multitude of extra-pulmonary comorbidities. Prior work using CT imaging has identified several clinically relevant subgroups of smoking related lung disease, but these investigations have generally lacked organ specific molecular correlates. RESEARCH QUESTION: Can CT imaging be used to identify clinical phenotypes of smoking related lung disease that have specific bronchial epithelial gene expression patterns to better understand disease pathogenesis? STUDY DESIGN AND METHODS: Using K-means clustering, we clustered participants from the COPDGene study (n = 5,273) based on CT imaging characteristics and then evaluated their clinical phenotypes. These clusters were replicated in the Detection of Early Lung Cancer Among Military Personnel (DECAMP) cohort (n = 360), and were further characterized using bronchial epithelial gene expression.
RESULTS: Three clusters (preserved, interstitial predominant and emphysema predominant) were identified. Compared to the preserved cluster, the interstitial and emphysema clusters had worse lung function, exercise capacity and quality of life. In longitudinal follow-up, individuals from the emphysema group had greater declines in exercise capacity and lung function, more emphysema, more exacerbations, and higher mortality. Similarly, genes involved in inflammatory pathways (tumor necrosis factor-α, interferon-β) are more highly expressed in bronchial epithelial cells from individuals in the emphysema cluster, while genes associated with T-cell related biology are decreased in these samples. Samples from individuals in the interstitial cluster generally had intermediate levels of expression of these genes.
INTERPRETATION: Using quantitative CT imaging, we identified three groups of individuals in older ever-smokers that replicate in two cohorts. Airway gene expression differences between the three groups suggests increased levels of inflammation in the most severe clinical phenotype, possibly mediated by the tumor necrosis factor-α and interferon-β pathways. CLINICAL TRIAL REGISTRATION: COPDGene (NCT00608764), DECAMP-1 (NCT01785342), DECAMP-2 (NCT02504697).
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; airway gene expression; diagnostic imaging; gene expression; imaging; interferon

Mesh:

Year:  2020        PMID: 32946850      PMCID: PMC8039011          DOI: 10.1016/j.chest.2020.08.2115

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   10.262


  57 in total

1.  The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis.

Authors:  J G LEOPOLD; J GOUGH
Journal:  Thorax       Date:  1957-09       Impact factor: 9.139

2.  Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.

Authors:  Joyce D Schroeder; Alexander S McKenzie; Jordan A Zach; Carla G Wilson; Douglas Curran-Everett; Douglas S Stinson; John D Newell; David A Lynch
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

3.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

4.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.

Authors:  Stephen I Rennard; Nicholas Locantore; Bruno Delafont; Ruth Tal-Singer; Edwin K Silverman; Jørgen Vestbo; Bruce E Miller; Per Bakke; Bartolomé Celli; Peter M A Calverley; Harvey Coxson; Courtney Crim; Lisa D Edwards; David A Lomas; William MacNee; Emiel F M Wouters; Julie C Yates; Ignacio Coca; Alvar Agustí
Journal:  Ann Am Thorac Soc       Date:  2015-03

7.  Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Authors:  Rachel K Putman; Hiroto Hatabu; Tetsuro Araki; Gunnar Gudmundsson; Wei Gao; Mizuki Nishino; Yuka Okajima; Josée Dupuis; Jeanne C Latourelle; Michael H Cho; Souheil El-Chemaly; Harvey O Coxson; Bartolome R Celli; Isis E Fernandez; Oscar E Zazueta; James C Ross; Rola Harmouche; Raúl San José Estépar; Alejandro A Diaz; Sigurdur Sigurdsson; Elías F Gudmundsson; Gudny Eiríksdottír; Thor Aspelund; Matthew J Budoff; Gregory L Kinney; John E Hokanson; Michelle C Williams; John T Murchison; William MacNee; Udo Hoffmann; Christopher J O'Donnell; Lenore J Launer; Tamara B Harrris; Vilmundur Gudnason; Edwin K Silverman; George T O'Connor; George R Washko; Ivan O Rosas; Gary M Hunninghake
Journal:  JAMA       Date:  2016-02-16       Impact factor: 56.272

8.  Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.

Authors:  Stefania Crotta; Sophia Davidson; Tanel Mahlakoiv; Christophe J Desmet; Matthew R Buckwalter; Matthew L Albert; Peter Staeheli; Andreas Wack
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

9.  Antiviral immunity is impaired in COPD patients with frequent exacerbations.

Authors:  Aran Singanayagam; Su-Ling Loo; Maria Calderazzo; Lydia J Finney; Maria-Belen Trujillo Torralbo; Eteri Bakhsoliani; Jason Girkin; Punnam Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew Reid; Joseph Footitt; Peter A B Wark; Christopher L Grainge; Sebastian L Johnston; Nathan W Bartlett; Patrick Mallia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-12       Impact factor: 5.464

10.  Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd.

Authors:  Zichen Wang; Caroline D Monteiro; Kathleen M Jagodnik; Nicolas F Fernandez; Gregory W Gundersen; Andrew D Rouillard; Sherry L Jenkins; Axel S Feldmann; Kevin S Hu; Michael G McDermott; Qiaonan Duan; Neil R Clark; Matthew R Jones; Yan Kou; Troy Goff; Holly Woodland; Fabio M R Amaral; Gregory L Szeto; Oliver Fuchs; Sophia M Schüssler-Fiorenza Rose; Shvetank Sharma; Uwe Schwartz; Xabier Bengoetxea Bausela; Maciej Szymkiewicz; Vasileios Maroulis; Anton Salykin; Carolina M Barra; Candice D Kruth; Nicholas J Bongio; Vaibhav Mathur; Radmila D Todoric; Udi E Rubin; Apostolos Malatras; Carl T Fulp; John A Galindo; Ruta Motiejunaite; Christoph Jüschke; Philip C Dishuck; Katharina Lahl; Mohieddin Jafari; Sara Aibar; Apostolos Zaravinos; Linda H Steenhuizen; Lindsey R Allison; Pablo Gamallo; Fernando de Andres Segura; Tyler Dae Devlin; Vicente Pérez-García; Avi Ma'ayan
Journal:  Nat Commun       Date:  2016-09-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.